Literature DB >> 12522002

Unrelated donor hematopoietic cell transplantation: marrow or umbilical cord blood?

Satkiran S Grewal1, Juliet N Barker, Stella M Davies, John E Wagner.   

Abstract

Entities:  

Mesh：

Year:  2003        PMID： 12522002     DOI： 10.1182/blood-2002-08-2510

Source DB:  PubMed          Journal:  Blood        ISSN： 0006-4971            Impact factor:   22.113


× No keyword cloud information.
  59 in total

1.  Optimized multiparametric immunophenotyping of umbilical cord blood cells by flow cytometry.

Authors:  Christina Basford; Nico Forraz; Colin McGuckin
Journal:  Nat Protoc       Date:  2010-06-24       Impact factor: 13.491

Review 2.  Hematologic aspects of myeloablative therapy and bone marrow transplantation.

Authors:  Roger S Riley; Michael Idowu; Alden Chesney; Shawn Zhao; John McCarty; Lawrence S Lamb; Jonathan M Ben-Ezra
Journal:  J Clin Lab Anal       Date:  2005       Impact factor: 2.352

3.  Differentiation of naive cord-blood T cells into CD19-specific cytolytic effectors for posttransplantation adoptive immunotherapy.

Authors:  Lisa Marie Serrano; Timothy Pfeiffer; Simon Olivares; Tontanai Numbenjapon; Jennifer Bennitt; Daniel Kim; David Smith; George McNamara; Zaid Al-Kadhimi; Joseph Rosenthal; Stephen J Forman; Michael C Jensen; Laurence J N Cooper
Journal:  Blood       Date:  2005-12-13       Impact factor: 22.113

Review 4.  Novel approaches in allogeneic stem cell transplantation.

Authors:  Esperanza B Papadopoulos; Ann A Jakubowski
Journal:  Curr Oncol Rep       Date:  2006-09       Impact factor: 5.075

5.  Posttransplantation engraftment and safety of cord blood transplantation with grafts containing relatively low cell doses in adults.

Authors:  Satoshi Takahashi; Jun Ooi; Akira Tomonari; Takaaki Konuma; Nobuhiro Tsukada; Arinobu Tojo; Takuhiro Yamaguchi; Shigetaka Asano
Journal:  Int J Hematol       Date:  2006-11       Impact factor: 2.490

6.  Unrelated cord blood transplantation with a reduced-intensity conditioning regimen following autologous transplantation for multiple myeloma.

Authors:  Toshiki Yamada; Akira Tomonari; Satoshi Takahashi; Jun Ooi; Tohru Iseki; Yoko Shimohakamada; Kashiya Takasugi; Nobuhiro Ohno; Fumitaka Nagamura; Kaoru Uchimaru; Arinobu Tojo; Hisataka Moriwaki; Shigetaka Asano
Journal:  Int J Hematol       Date:  2004-11       Impact factor: 2.490

7.  Acute graft-versus-host disease after unrelated donor umbilical cord blood transplantation: analysis of risk factors.

Authors:  Margaret L MacMillan; Daniel J Weisdorf; Claudio G Brunstein; Qing Cao; Todd E DeFor; Michael R Verneris; Bruce R Blazar; John E Wagner
Journal:  Blood       Date:  2008-11-07       Impact factor: 22.113

Review 8.  Principles and overview of allogeneic hematopoietic stem cell transplantation.

Authors:  Sergio Giralt; Michael R Bishop
Journal:  Cancer Treat Res       Date:  2009

9.  Successful treatment of acute myelogenous leukemia with favorable cytogenetics by reduced-intensity stem cell transplantation.

Authors:  Takeshi Kondo; Atsushi Yasumoto; Kotaro Arita; Jun-Ichi Sugita; Akio Shigematsu; Kohei Okada; Mutsumi Takahata; Masahiro Onozawa; Kaoru Kahata; Yukari Takeda; Masato Obara; Satoshi Yamamoto; Tomoyuki Endo; Mitsufumi Nishio; Norihiro Sato; Junji Tanaka; Satoshi Hashino; Takao Koike; Masahiro Asaka; Masahiro Imamura
Journal:  Int J Hematol       Date:  2010-01-20       Impact factor: 2.490

Review 10.  Low dose total body irradiation followed by allogeneic lymphocyte infusion for refractory hematologic malignancy--an updated review.

Authors:  Karen K Ballen; Gerald Colvin; David Porter; Peter J Quesenberry
Journal:  Leuk Lymphoma       Date:  2004-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.